Regulation of the Rapsyn Promoter by Kaiso and δ-Catenin

REFERENCES

• Abicht, A., Stucka R., Schmidt C., Briguet A., Hopfner S., Song I. H., Pongratz D., Muller-Felber W., Ruegg M. A., and Lochmuller H.. 2002. A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome. Brain 125:1005–1013.
   PubMedGoogle Scholar
• Askanas, V., Engel W. K., Yang C. C., Alvarez R. B., Lee V. M., and Wisniewski T.. 1998. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am. J. Pathol. 152:889–895.
   PubMedGoogle Scholar
• Bardwell, V. J., and Treisman R.. 1994. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8:1664–1677.
   PubMed Web of Science ®Google Scholar
• Bereshchenko, O. R., Gu W., and Dalla-Favera R.. 2002. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32:606–613.
   PubMed Web of Science ®Google Scholar
• Cifuentes-Diaz, C., Bitoun M., Goudou D., Seddiqi N., Romero N., Rieger F., Perin J. P., and Alliel P. M.. 2004. Neuromuscular expression of the BTB/POZ and zinc finger protein myoneurin. Muscle Nerve 29:59–65.
   PubMedGoogle Scholar
• Daniel, J. M., and Reynolds A. B.. 1999. The catenin p120ctn interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol. Cell. Biol. 19:3614–3623.
   PubMed Web of Science ®Google Scholar
• Daniel, J. M., Ireton R. C., and Reynolds A. B.. 2001. Monoclonal antibodies to Kaiso: a novel transcription factor and p120ctn-binding protein. Hybridoma 20:159–166.
   PubMedGoogle Scholar
• Daniel, J. M., Spring C. M., Crawford H. C., Reynolds A. B., and Baig A.. 2002. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 30:2911–2919.
   PubMed Web of Science ®Google Scholar
• de Kerchove D'Exaerde, A., Cartaud J. R., and Schaeffer L.. 2002. Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression. EMBO Rep. 3:1075–1081. (First published 22 October 2002; 10.1093/embo-reports/kvf220.)
   PubMedGoogle Scholar
• Deltour, S., Pinte S., Guerardel C., Wasylyk B., and Leprince D.. 2002. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell. Biol. 22:4890–4901.
   PubMedGoogle Scholar
• Duclert, A., Savatier N., Schaeffer L., and Changeux J. P.. 1996. Identification of an element crucial for the sub-synaptic expression of the acetylcholine receptor epsilon-subunit gene. J. Biol. Chem. 271:17433–17438.
   PubMed Web of Science ®Google Scholar
• Dunne, V., and Maselli R. A.. 2003. Identification of pathogenic mutations in the human rapsyn gene. J. Hum. Genet. 48:204–207.
   PubMed Web of Science ®Google Scholar
• Faucheux, M., Roignant J. Y., Netter S., Charollais J., Antoniewski C., and Theodore L.. 2003. batman interacts with Polycomb and trithorax group genes and encodes a BTB/POZ protein that is included in a complex containing GAGA factor. Mol. Cell. Biol. 23:1181–1195.
   PubMedGoogle Scholar
• Fedele, M., Benvenuto G., Pero R., Majello B., Battista S., Lembo F., Vollono E., Day P. M., Santoro M., Lania L., Bruni C. B., Fusco A., and Chiariotti L.. 2000. A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J. Biol. Chem. 275:7894–7901.
   PubMedGoogle Scholar
• Finn, A. J., Feng G., and Pendergast A. M.. 2003. Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction. Nat. Neurosci. 6:717–723.
   PubMed Web of Science ®Google Scholar
• Fischbach, G. D. 1972. Synapse formation between dissociated nerve and muscle cells in low density cell cultures. Dev. Biol. 28:407–429.
   PubMed Web of Science ®Google Scholar
• Gautam, M., Noakes P. G., Mudd J., Nichol M., Chu G. C., Sanes J. R., and Merlie J. P.. 1995. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377:232–236.
   PubMed Web of Science ®Google Scholar
• Ho, C., Zhou J., Medina M., Goto T., Jacobson M., Bhide P. G., and Kosik K. S.. 2000. δ-Catenin is a nervous system-specific adherens junction protein which undergoes dynamic relocalization during development. J. Comp. Neurol. 420:261–276.
   PubMed Web of Science ®Google Scholar
• Javahery, R., Khachi A., Lo K., Zenzie-Gregory B., and Smale S. T.. 1994. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14:116–127.
   PubMed Web of Science ®Google Scholar
• Jones, S. B., Lanford G. W., Chen Y. H., Moribito M., Kim K., and Lu Q.. 2002. Glutamate-induced delta-catenin redistribution and dissociation from postsynaptic receptor complexes. Neuroscience 115:1009–1021.
   PubMedGoogle Scholar
• Kelly, K. F., Spring C. M., Otchere A. A., and Daniel J. M.. 2004. NLS-dependant nuclear localization of p120 ctn is necessary to relieve Kaiso-mediated transcriptional repression. J. Cell Sci. 117:2675–2686.
   PubMed Web of Science ®Google Scholar
• Kim, K., Sirota A., Chen Y. H., Jones S. B., Dudek R., Lanford G. W., Thakore C., and Lu Q.. 2002. Dendrite-like process formation and cytoskeletal remodeling regulated by delta-catenin expression. Exp. Cell Res. 275:171–184.
   PubMedGoogle Scholar
• Kim, S. W., Fang X., Ji H., Paulson A. F., Daniel J. M., Ciesiolka M., van Roy F., and McCrea P. D.. 2002. Isolation and characterization of XKaiso, a transcriptional repressor that associates with the catenin Xp120(ctn) in Xenopus laevis. J. Biol. Chem. 277:8202–8208.
   PubMedGoogle Scholar
• Kobayashi, A., Yamagiwa H., Hoshino H., Muto A., Sato K., Morita M., Hayashi N., Yamamoto M., and Igarashi K.. 2000. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol. Cell. Biol. 20:1733–1746.
   PubMedGoogle Scholar
• Koike, S., Schaeffer L., and Changeux J. P.. 1995. Identification of a DNA element determining synaptic expression of the mouse acetylcholine receptor delta-subunit gene. Proc. Natl. Acad. Sci. USA 92:10624–10628.
   PubMedGoogle Scholar
• Lu, Q., Paredes M., Medina M., Zhou J., Cavallo R., Peifer M., Orecchio L., and Kosik K. S.. 1999. δ-Catenin, an adhesive junction-associated protein which promotes cell scattering. J. Cell Biol. 144:519–532.
   PubMed Web of Science ®Google Scholar
• Lu, Q., Mukhopadhyay N. K., Griffin J. D., Paredes M., Medina M., and Kosik K. S.. 2002. Brain armadillo protein delta-catenin interacts with Abl tyrosine kinase and modulates cellular morphogenesis in response to growth factors. J. Neurosci. Res. 67:618–624.
   PubMed Web of Science ®Google Scholar
• Moscoso, L. M., Merlie J. P., and Sanes J. R.. 1995. N-CAM, 43K-rapsyn, and S-laminin mRNAs are concentrated at synaptic sites in muscle fibers. Mol. Cell. Neurosci. 6:80–89.
   PubMed Web of Science ®Google Scholar
• Muller, J. S., Mildner G., Muller-Felber W., Schara U., Krampfl K., Petersen B., Petrova S., Stucka R., Mortier W., Bufler J., Kurlemann G., Huebner A., Merlini L., Lochmuller H., and Abicht A.. 2003. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology 60:1805–1810.
   PubMedGoogle Scholar
• Nichols, P., Croxen R., Vincent A., Rutter R., Hutchinson M., Newsom-Davis J., and Beeson D.. 1999. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. Ann. Neurol. 45:439–443.
   PubMedGoogle Scholar
• Ohno, K., Anlar B., and Engel A. G.. 1999. Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene. Neuromuscul. Disord. 9:131–135.
   PubMedGoogle Scholar
• Ohno, K., Engel A. G., Shen X. M., Selcen D., Brengman J., Harper C. M., Tsujino A., and Milone M.. 2002. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am. J. Hum. Genet. 70:875–885.
   PubMedGoogle Scholar
• Ohno, K., Sadeh M., Blatt I., Brengman J. M., and Engel A. G.. 2003. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome. Hum. Mol. Genet. 12:739–748.
   PubMed Web of Science ®Google Scholar
• Paffenholz, R., and Franke W. W.. 1997. Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family. Differentiation 61:293–304.
   PubMedGoogle Scholar
• Peukert, K., Staller P., Schneider A., Carmichael G., Hänel F., and Eilers M.. 1997. An alternative pathway for gene regulation by Myc. EMBO J. 16:5672–5686.
   PubMed Web of Science ®Google Scholar
• Prokhortchouk, A., Hendrich B., Jorgensen H., Ruzov A., Wilm M., Georgiev G., Bird A., and Prokhortchouk E.. 2001. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15:1613–1618.
   PubMed Web of Science ®Google Scholar
• Reynolds, A. B., Daniel J., McCrea P. D., Wheelock M. J., Wu J., and Zhang Z.. 1994. Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol. Cell. Biol. 14:8333–8342.
   PubMed Web of Science ®Google Scholar
• Richard, P., Gaudon K., Andreux F., Yasaki E., Prioleau C., Bauche S., Barois A., Ioos C., Mayer M., Routon M. C., Mokhtari M., Leroy J. P., Fournier E., Hainque B., Koenig J., Fardeau M., Eymard B., and Hantai D.. 2003. Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes. J. Med. Genet. 40:e81. [Online.]
   PubMedGoogle Scholar
• Rodova, M., Islam M. R., Maser R. L., and Calvet J. P.. 2002. The polycystic kidney disease-1 promoter is a target of the beta-catenin/T-cell factor pathway. J. Biol. Chem. 277:29577–29583.
   PubMedGoogle Scholar
• Sanes, J. R., and Lichtman J. W.. 1999. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22:389–442.
   PubMed Web of Science ®Google Scholar
• Schaeffer, L., de Kerchove D'Exaerde A., and Changeux J. P.. 2001. Targeting transcription to the neuromuscular synapse. Neuron 31:15–22.
   PubMed Web of Science ®Google Scholar
• Wallace, B. G. 1986. Aggregating factor from Torpedo electric organ induces patches containing acetylcholine receptors, acetylcholinesterase, and butyrylcholinesterase on cultured myotubes. J. Cell Biol. 102:783–794.
   PubMed Web of Science ®Google Scholar
• Weinmann, A. S., and Farnham P. J.. 2002. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26:37–47.
   PubMed Web of Science ®Google Scholar
• Weintraub, H., Dwarki V. J., Verma I., Davis R., Hollenberg S., Snider L., Lassar A., and Tapscott S. J.. 1991. Muscle-specific transcriptional activation by MyoD. Genes Dev. 5:1377–1386.
   PubMed Web of Science ®Google Scholar
• Yoon, H. G., Chan D. W., Reynolds A. B., Qin J., and Wong J.. 2003. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 12:723–734.
   PubMed Web of Science ®Google Scholar
• Zhou, J., Liyanage U., Medina M., Ho C., Simmons A. D., Lovett M., and Kosik K. S.. 1997. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8:2085–2090.
   PubMedGoogle Scholar